Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New dates and a specific address in Groningen, Netherlands have been added, while several earlier dates and a related FDA section have been removed.
    Difference
    0.7%
    Check dated 2024-10-10T14:59:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has added FDA Safety Alerts and Recalls in the new revision v2.11.2, replacing the previous revision v2.11.0.
    Difference
    0.2%
    Check dated 2024-10-03T05:40:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.
    Difference
    0.7%
    Check dated 2024-09-25T23:19:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    ClinicalTrials.gov has acknowledged delays in displaying study record information and has updated to revision v2.10.5, replacing the previous v2.10.3.
    Difference
    0.6%
    Check dated 2024-09-18T17:19:31.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.3, with the notable removal of FDA Safety Alerts and Recalls from the previous version 2.10.2.
    Difference
    0.2%
    Check dated 2024-09-04T06:35:46.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T01:08:08.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.